Osmosis Investment Management Revised Equity Factor Definitions

The firm has updated its investment framework to account for research and development spending in equity calculations.

Updated on Oct. 1, 2026 in Investing

Osmosis Investment Management Revised Equity Factor Definitions

Live Poll

Is now a good time to prioritize companies with high research and development spending?

Osmosis Investment Management has revised its Value equity factor to include research and development spending as an asset. Additionally, the firm launched 48 new iSTOXX Osmosis Multi Factor Transition Indices.

Why it matters

Traditional financial measures often fail to capture the true value creation stemming from research and development investments. By integrating these costs, the firm aims to better reflect corporate value and mitigate financial risks associated with resource efficiency.

Osmosis Investment Management currently manages $17 billion in assets, or approximately €15 billion. The firm has now deployed 48 newly launched iSTOXX Osmosis Multi Factor Transition Indices.

The players

Osmosis Investment Management

This investment firm manages $17 billion in assets and specializes in developing index strategies that incorporate environmental and research-focused data.

STOXX

This global provider of index solutions collaborated with Osmosis to launch the new Multi Factor Transition Indices series.

The details

The firm adds accumulated research and development spending back into investment calculations to provide a more accurate valuation of modern corporations. This methodology complements its resource efficiency measure, which evaluates carbon emissions, water consumption, and waste production relative to company revenue.

Mid-2000s: Research and development spending began to rise significantly relative to production costs among US companies.
Past 18 months: Osmosis Investment Management engaged with various pension funds to test these updated financial models.
October 1, 2026: Official publication of the announcement.

Investing
Sept. 28
Adhesion Wealth Partnered with Fidelity Investments
Investing
Sept. 25
Northern Trust Will Convert Mutual Funds into ETFs
Investing
Sept. 28
SEC Issued Guidance on Private Asset Valuation

Market Dynamics

The firm's strategy follows the broader documented trend of rising intangible assets in US corporate balance sheets since the mid-2000s. By accounting for research and development as a core asset, this shift mirrors the industry's move toward valuing long-term innovation over traditional production costs.

Retail and institutional investors can expect new benchmarks for evaluating corporate value beyond traditional financial metrics. This change may impact portfolio allocations as investors increasingly focus on firms with high research-driven asset growth.

The takeaway

Investors should consider how research and development spending alters the perceived value of their holdings in the current market. Reviewing portfolio exposure to indices that weight innovation can help align investment strategies with modern corporate realities.